Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$200.67
3.751.90%
At close: Dec 16, 4:00 PM EST
$200.67
N/A
After Hours: 4:04 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Insmed (INSM) stock?
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Who are Insmed (INSM) competitors?
Other companies in Insmed’s space includes: BeOne Medicines Ltd (NASDAQ:ONC), Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).
What is the forecast, or price target, for Insmed (INSM) stock?
Insmed has a consensus price target of $176.71.
What is the current price for Insmed (INSM)?
The stock price for Insmed (NASDAQ: INSM) is $200.67 last updated December 16, 2025 at 4:04 PM EST.
Does Insmed (INSM) pay a dividend?
There are no upcoming dividends for Insmed.
When is Insmed (NASDAQ:INSM) reporting earnings?
Insmed does not have any upcoming earnings scheduled.
Is Insmed (INSM) going to split?
There is no upcoming split for Insmed.
What sector and industry does Insmed (INSM) operate in?
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
